Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study

Felix Greimel,1 Christine Scheuerer,1 Andre Gessner,2 Michaela Simon,2 Thomas Kalteis,1 Joachim Grifka,1 Achim Benditz,1 Hans-Robert Springorum,1 Jens Schaumburger1 1Department of Orthopedics, University Medical Center Regensburg, Asklepios Klinikum Bad Abbach, Bad Abbach, 2Institute of Cl...

Full description

Bibliographic Details
Main Authors: Greimel F, Scheuerer C, Gessner A, Simon M, Kalteis T, Grifka J, Benditz A, Springorum HR, Schaumburger J
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/efficacy-of-antibiotic-treatment-of-implant-associated-staphylococcus--peer-reviewed-article-DDDT
_version_ 1829105462824402944
author Greimel F
Scheuerer C
Gessner A
Simon M
Kalteis T
Grifka J
Benditz A
Springorum HR
Schaumburger J
author_facet Greimel F
Scheuerer C
Gessner A
Simon M
Kalteis T
Grifka J
Benditz A
Springorum HR
Schaumburger J
author_sort Greimel F
collection DOAJ
description Felix Greimel,1 Christine Scheuerer,1 Andre Gessner,2 Michaela Simon,2 Thomas Kalteis,1 Joachim Grifka,1 Achim Benditz,1 Hans-Robert Springorum,1 Jens Schaumburger1 1Department of Orthopedics, University Medical Center Regensburg, Asklepios Klinikum Bad Abbach, Bad Abbach, 2Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Regensburg, Bavaria, Germany Abstract: The efficacy of antibiotic monotherapy and combination therapy in the treatment of implant-associated infection by Staphylococcus aureus was evaluated in an animal study. The femoral medullary cavity of 66 male Wistar rats was contaminated with S. aureus (ATCC 29213) and a metal device was implanted, of which 61 could be evaluated. Six treatment groups were studied: flucloxacillin, flucloxacillin in combination with rifampin, moxifloxacin, moxifloxacin in combination with rifampin, rifampin, and a control group with aqua. The treatment was applied for 14 days. After euthanasia, the bacterial counts in the periprosthetic bone, the soft tissue, and the implant-associated biofilm were measured. Both antibiotic combination treatments (moxifloxacin plus rifampin and flucloxacillin plus rifampin) achieved a highly significant decrease in microbial counts in the bone and soft tissue and in the biofilm. Mono-antibiotic treatments with either moxifloxacin or flucloxacillin were unable to achieve a significant decrease in microbial counts in bone and soft tissue or the biofilm, whilst rifampin was able to reduce the counts significantly only in the biofilm. Antibiotic resistance was measured in 1/3 of the cases in the rifampin group, whereas no resistance was measured in all other groups. The results show that combinations of both moxifloxacin and flucloxacillin plus rifampin are adequate for the treatment of periprosthetic infections due to infections with S. aureus, whereas monotherapies are not effective or not applicable due to the rapid development of antibiotic resistance. Therefore, moxifloxacin is an effective alternative in combination with rifampin for the treatment of implant-associated infections. Keywords: moxifloxacin, rifampin, flucloxacillin, implant-associated infection, prosthetic infection, Staphylococcus aureus
first_indexed 2024-12-12T06:07:42Z
format Article
id doaj.art-0aa91b9ed1fd41098555c63b0de46dc4
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-12T06:07:42Z
publishDate 2017-06-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-0aa91b9ed1fd41098555c63b0de46dc42022-12-22T00:35:15ZengDove Medical PressDrug Design, Development and Therapy1177-88812017-06-01Volume 111729173633284Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal studyGreimel FScheuerer CGessner ASimon MKalteis TGrifka JBenditz ASpringorum HRSchaumburger JFelix Greimel,1 Christine Scheuerer,1 Andre Gessner,2 Michaela Simon,2 Thomas Kalteis,1 Joachim Grifka,1 Achim Benditz,1 Hans-Robert Springorum,1 Jens Schaumburger1 1Department of Orthopedics, University Medical Center Regensburg, Asklepios Klinikum Bad Abbach, Bad Abbach, 2Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Regensburg, Bavaria, Germany Abstract: The efficacy of antibiotic monotherapy and combination therapy in the treatment of implant-associated infection by Staphylococcus aureus was evaluated in an animal study. The femoral medullary cavity of 66 male Wistar rats was contaminated with S. aureus (ATCC 29213) and a metal device was implanted, of which 61 could be evaluated. Six treatment groups were studied: flucloxacillin, flucloxacillin in combination with rifampin, moxifloxacin, moxifloxacin in combination with rifampin, rifampin, and a control group with aqua. The treatment was applied for 14 days. After euthanasia, the bacterial counts in the periprosthetic bone, the soft tissue, and the implant-associated biofilm were measured. Both antibiotic combination treatments (moxifloxacin plus rifampin and flucloxacillin plus rifampin) achieved a highly significant decrease in microbial counts in the bone and soft tissue and in the biofilm. Mono-antibiotic treatments with either moxifloxacin or flucloxacillin were unable to achieve a significant decrease in microbial counts in bone and soft tissue or the biofilm, whilst rifampin was able to reduce the counts significantly only in the biofilm. Antibiotic resistance was measured in 1/3 of the cases in the rifampin group, whereas no resistance was measured in all other groups. The results show that combinations of both moxifloxacin and flucloxacillin plus rifampin are adequate for the treatment of periprosthetic infections due to infections with S. aureus, whereas monotherapies are not effective or not applicable due to the rapid development of antibiotic resistance. Therefore, moxifloxacin is an effective alternative in combination with rifampin for the treatment of implant-associated infections. Keywords: moxifloxacin, rifampin, flucloxacillin, implant-associated infection, prosthetic infection, Staphylococcus aureushttps://www.dovepress.com/efficacy-of-antibiotic-treatment-of-implant-associated-staphylococcus--peer-reviewed-article-DDDTmoxifloxacinrifampinflucloxacillinimplant-associated infectionprosthetic infectionstaphylococcus aureus
spellingShingle Greimel F
Scheuerer C
Gessner A
Simon M
Kalteis T
Grifka J
Benditz A
Springorum HR
Schaumburger J
Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
Drug Design, Development and Therapy
moxifloxacin
rifampin
flucloxacillin
implant-associated infection
prosthetic infection
staphylococcus aureus
title Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
title_full Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
title_fullStr Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
title_full_unstemmed Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
title_short Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
title_sort efficacy of antibiotic treatment of implant associated staphylococcus aureus infections with moxifloxacin flucloxacillin rifampin and combination therapy an animal study
topic moxifloxacin
rifampin
flucloxacillin
implant-associated infection
prosthetic infection
staphylococcus aureus
url https://www.dovepress.com/efficacy-of-antibiotic-treatment-of-implant-associated-staphylococcus--peer-reviewed-article-DDDT
work_keys_str_mv AT greimelf efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT scheuererc efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT gessnera efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT simonm efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT kalteist efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT grifkaj efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT benditza efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT springorumhr efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy
AT schaumburgerj efficacyofantibiotictreatmentofimplantassociatedstaphylococcusaureusinfectionswithmoxifloxacinflucloxacillinrifampinandcombinationtherapyananimalstudy